ArticleAfrican journal of primary health care & family medicine2026
Lived experiences of ethical dilemmas in pricing life-saving medicines among private-sector pharmacists in Zimbabwe.
Article in African journal of primary health care & family medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccess to affordable medicines is central to primary health care and universal health coverage. In Zimbabwe, the absence of national price regulation and heavy out-of-pocket expenditure place private-sector pharmacists at the centre of difficult decisions, as they balance professional duty with business survival.
aimThis study aimed to explore the ethical dilemmas faced by pharmacists in Zimbabwe's private sector when pricing life-saving medicines and the coping mechanisms and support systems they employ.
settingThe study was conducted in private community pharmacies located in Harare and Bulawayo, Zimbabwe's two largest urban pharmaceutical markets.
methodsA qualitative interpretive phenomenological design was used. Semi-structured interviews were conducted with 12 pharmacists (6 Harare, 6 Bulawayo) who were purposively sampled from independent and chain pharmacies. Interviews were recorded, transcribed verbatim, and thematically analysed using Braun and Clarke's six-phase framework. NVivo supported coding.
resultsPharmacists described moral distress when patients could not afford medicines, particularly insulin and antihypertensives. Informal coping strategies included silent discounts, partial dispensing, referrals, and credit sales. Harare participants emphasised currency volatility and chain-store policies, whereas Bulawayo pharmacists highlighted community solidarity. All called for systemic support through ethical pricing guidelines, subsidy mechanisms, and professional forums.
conclusionEthical dilemmas in pricing are pervasive. Coping strategies provide temporary relief but are unsustainable and may compromise care. Systemic reforms are required to balance affordability with sustainable pharmacy practice.Contribution: This study highlights the moral dimension of medicine pricing in Zimbabwe and provides evidence to guide ethical frameworks, regulatory reforms, and professional support for equitable access to medicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.